GlassScriptPhysician profile
Cameron Zachary
NPI 1073191631
$1,391.93
in general payments reported to CMS, 2019-2025
9 companies · $594 in 2025
The $594 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $449 · 2024: $348 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239 · Education: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.07 |
| Education | $152.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $365.13 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $235.67 | 2023-2024 | Dupixent |
| Arcutis Biotherapeutics, INC. | $137.41 | 2025 | Zoryve |
| Abbvie INC. | $136.57 | 2025 | |
| Ucb, INC. | $128.41 | 2025 | Bimzelx |
| Lilly USA, LLC | $125.00 | 2024 | Olumiant |
| Botanix Sb INC | $122.31 | 2025 | Sofdra |
| Sanofi-Aventis U.S. LLC | $72.00 | 2024 | |
| Revance Therapeutics, INC. | $69.43 | 2025 | Daxxify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Zachary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.